Pixelworks Inc. (NASDAQ:PXLW) Stock Sees Buying Interest At Lower Levels: More to Come?

August 11, 2021

Pixelworks Inc. (NASDAQ:PXLW) jumped 15.5% after announcing 50% sequential and YOY growth in revenue in Q2 2021. The growth is attributable to string projector business recovery and continued growth in mobile revenue. Mobile revenue increased QOQ and YOY driven by enhanced adoption of software and hardware-based visual processing solutions in the increasing number of smartphone launches. ASUS unveiled Zenfone 8 flip and Zonefone 8 flagship phones that incorporate the company’s…

Read More >>

Xenetic BioSciences Inc. (NASDAQ:XBIO) Stock Sees Solid Buying Interest: Buy Now?

August 11, 2021

Xenetic BioSciences Inc. (NASDAQ:XBIO) jumped 14%. Recently, the company signed a sale and purchased a definitive agreement to purchase 4.63 million of its common shares by a healthcare-focused institutional investor. The company is offering the shares at $2.7 per share in an at-the-market private placement under the Nasdaq rules. Equally, the company agreed to provide the investor share purchase warrants to buy 4.63 million common shares. Notably, the contracts have…

Read More >>

NewAge Inc. (NASDAQ:NBEV) Stock Gains Momentum: How Far Can it Go?

August 11, 2021

NewAge Inc. (NASDAQ:NBEV) jumped 14% after announcing its Q2 2021 financial results, in which net revenue was $124 million. The company reported adjusted EBITDA of around $1.7 million, net income of $17.4 million, and basic EPS of $0.11. Net revenue increased 98% compared to a year ago. CEO Brent Willis said that Q2 2021 saw an increase in the bottom and topline results. Brent said that during the quarter, the…

Read More >>

Ziopharm Oncology Inc. (NASDAQ:ZIOP) Stock Takes a Hit: A Good Buy Now?

August 11, 2021

Ziopharm Oncology Inc. (NASDAQ:ZIOP) fell 16% after announcing Q2 2021 corporate updates. Interim CEO Heidi Hagen said that Ziopharm had made considerable progress on various fronts since the last update. The company had built positive momentum in the TCR-T Library clinical study enabling activities and strengthening the balance sheet. He explained that the quarterly update shows that the company is on track with what it had early set to attain….

Read More >>

Waitr Holdings Inc. (NASDAQ:WTRH) Stock Slumps After Earnings: Better to Avoid?

August 11, 2021

Waitr Holdings Inc. (NASDAQ:WTRH) fell 23% after the company missed Q2 estimates. The company announced revenue of $49.2 million in Q2 2021 comp-pared to $60.5 million a year ago. For the six months ending June 30, 2021, the company generated revenue of $100.1 million. Waitr reported an increase of average daily orders to 38,583 with active diners at the end of the quarter, consistent with the numbers reported in Q1…

Read More >>

Diffussion Pharma Inc. (NASDAQ:DFFN) Stock Attempts To Rebound: How to Trade Now?

August 11, 2021

Diffussion Pharma Inc. (NASDAQ:DFFN) jumped 4.5% on no company-specific news or release. Recently, the company released a topline result for the phase 1 study of its flagship product, trans sodium crocetinate (TSC). The company used transcutaneous oxygen monitoring hg in the trial to assess direct TSC pharmacodynamics effects on peripheral oxygenation of tissue in healthy individuals. The topline findings were based on primary endpoint data analysis which showed a promising…

Read More >>

Labor Smart Inc. (NASDAQ:LTNC) Stock Jumps After The News: Still a Buy?

August 11, 2021

Labor Smart Inc.’s (NASDAQ:LTNC) jumped 22% after its subsidiary Takeover Industries announced its product availability at retail giant Hy-Vee stores in the Midwest. Takeover Industries provides NXT LVL hydrogen-infused spring water as well as a nootropic energy shot.  The subsidiary will distribute the products to Hy-Vee’s 265 chain states and 175 convenient locations across Kansas, Illinois, Iowa, Minnesota, Nebraska, Wisconsin, Missouri, and Nebraska. The hydrogen-infused water has an endorsement from…

Read More >>

CytoDyn Inc. (OTCMKTS:CYDY) Stock Continues to Struggle At Lower Levels: Now What?

August 11, 2021

CytoDyn Inc. (OTCMKTS:CYDY) is down 6% in a week after announcing approval from Brazilian regulatory agency ANVISA for its previously submitted clinical study protocol to start patient recruitment in the CD17 study for severe coronavirus patients. The company will, in collaboration, conduct the trial with Academic Research Organisation Albert Einstein Israelite Hospital. The study will produce requisite data needed by ANVISA to consider leronlimab’s availability to patients with severe CPVID-19…

Read More >>

Nexus Energy Services (OTCMKTS:IBGR) Stock Goes Parabolic: Soars 270% This Week

August 11, 2021

Nexus Energy Services (OTCMKTS:IBGR) jumped 80% and up 270% in a week despite no fresh company news. Although the rally might have been speculative, it is still a massive chance for investors to be keen on the stock.  In July, a major announcement after the company, better known as DRYWORLD Brands Inc., secured Russian athlete Darya Klishina as an ambassador and shareholder. Klishina is a popular athlete globally and is…

Read More >>

Artificial Intelligence Technology Solutions Inc. (AITX) Stock Falls 10% in a Week: What Next?

August 11, 2021

Artificial Intelligence Technology Solutions Inc. (OTCMKTS:AITX) is down 10% in a week. The company’s subsidiary Robotic Assistance Devices Inc., has won a three-unit ROSA180 order from a leading auto group in North California. In addition, the company said that the client had recently ordered 6 ROSA180 units for dealership location protection despite not naming the customer. Robotics Assistance Devices CEO Steve Renharz said the order is repeated order as ROSA180…

Read More >>